हिंदी में पढ़ें

Bharat Biotech

Bharat Biotech launches oral cholera vaccine

Bharat Biotech launches oral cholera vaccine

Tue, Aug 27, 2024

Bharat Biotech International Ltd has launched Hillchol (BBV131), a novel single-strain oral cholera vaccine developed under license from Hilleman Laboratories.

Bharat Biotech, University of Sydney ink pact for vaccine research collaboration

Bharat Biotech, University of Sydney ink pact for vaccine research collaboration

Tue, Nov 28, 2023

Vaccines major Bharat Biotech International Ltd on Tuesday said it has entered into a collaboration with the University of Sydney Infectious Diseases Institute to advance vaccine research initiatives, strengthen academic-industry partnerships and augment global efforts to combat infectious diseases.

Bharat Biotech Reveals Prices For Nasal Vaccine In Private And Government Hospitals

Bharat Biotech Reveals Prices For Nasal Vaccine In Private And Government Hospitals

Tue, Dec 27, 2022

The price for one dose of Bharat Biotech’s intranasal vaccine iNCOVACC has been revealed. Bharat Biotech’s iNNOVACC is now available on CoWin, priced at ₹800 for private hospitals and ₹325 for a government hospitals. Know the complete details from Ambarish Pandey in this video.

TRENDING NOW

Bharat Biotech announces price of nasal vaccine - Check How Much It Costs?

Bharat Biotech announces price of nasal vaccine - Check How Much It Costs?

Tue, Dec 27, 2022

Bharat Biotech has announced the price of the world's first nasal Covid-19 vaccine - iNCOVACC.

Coronavirus: Bharat Biotech announces price of nasal vaccine - check details | Covid-19 Vaccine

Coronavirus: Bharat Biotech announces price of nasal vaccine - check details | Covid-19 Vaccine

Tue, Dec 27, 2022

Hyderabad-based biotechnology company Bharat Biotech has announced the price of the world's first nasal Covid-19 vaccine - iNCOVACC.

Bharat Biotech's Nasal Vaccine To Be Available On CoWIN App From Today

Bharat Biotech's Nasal Vaccine To Be Available On CoWIN App From Today

Fri, Dec 23, 2022

Nasal vaccine of Bharat Biotech has been approved. Nasal vaccine will be available on COWIN platform from today. This vaccine will be administered as a booster dose. Currently, nasal vaccine will be given in private hospitals.

iNCOVACC, world's first nasal Covid-19 vaccine manufactured by Bharat Biotech, approved for emergency use

iNCOVACC, world's first nasal Covid-19 vaccine manufactured by Bharat Biotech, approved for emergency use

Mon, Nov 28, 2022

iNCOVACC is the world's first intranasal vaccine for Covid to receive approval for a primary 2-dose schedule and heterologous booster dose.

Big Boost to India's Covid-19 fight: India's first nasal vaccine cleared for use

Big Boost to India's Covid-19 fight: India's first nasal vaccine cleared for use

Tue, Sep 06, 2022

BBV154 has been specifically formulated to allow intranasal delivery. In addition, the nasal delivery system has been designed and developed to be cost-effective in low and middle-income countries, the vaccine maker had said.

India’s first intranasal Covid-19 vaccine trial over, Bharat Biotech calls it safe and immunogenic

India’s first intranasal Covid-19 vaccine trial over, Bharat Biotech calls it safe and immunogenic

Mon, Aug 15, 2022

BBV154 has been specifically formulated to allow intranasal delivery. In addition, the nasal delivery system has been designed and developed to be cost-effective in low and middle-income countries, a press release from the vaccine maker said.

Vaccination for children: DGCI approves Covaxin for restricted emergency use in children aged 6-12 years

Vaccination for children: DGCI approves Covaxin for restricted emergency use in children aged 6-12 years

Tue, Apr 26, 2022

The Central Drugs Standard Control Organisation has given approval to the Bharat Biotech Vaccine for use in children aged between 6-12 years on April 26, 2022.

Covid-19: Bharat Biotech's Covaxin, Serum Institute's Covishield vaccines get 'Conditional Market Authorization' approval form DCGI - details here!

Covid-19: Bharat Biotech's Covaxin, Serum Institute's Covishield vaccines get 'Conditional Market Authorization' approval form DCGI - details here!

Thu, Jan 27, 2022

DCGI on Thursday gave its nod for market authorization of two COVID-19 vaccines - Covaxin and Covishield subject to certain conditions. Consent came after the the Subject Expert Committee of CDSCO recommended for upgradation of status for vaccines from restricted use in emergency situations to grant of new drug permission

Covid19: After getting regular market approval, each dose of Covishield, Covaxin likely to cost this

Covid19: After getting regular market approval, each dose of Covishield, Covaxin likely to cost this

Wed, Jan 26, 2022

The price of Covaxin is at Rs 1,200 per dose as of now while Covishield costs Rs 780 in private facilities. The prices include Rs 150 service charge. Both the vaccines are only authorised for emergency use in the country

WHO grants emergency use listing to Covaxin

WHO grants emergency use listing to Covaxin

Wed, Nov 03, 2021

The World Health Organization has granted emergency use listing (EUL) to Covaxin.

WHO to decide on Bharat Biotech's Covaxin emergency usage in October

WHO to decide on Bharat Biotech's Covaxin emergency usage in October

Thu, Sep 30, 2021

The World Health Organisation (WHO) has informed that the final decision on Bharat Biotech`s submission on emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October 2021.

BOOSTER DOSE! Govt APPROVES Bharat Biotech's Covaxin vaccine manufacturing facility in Gujarat

BOOSTER DOSE! Govt APPROVES Bharat Biotech's Covaxin vaccine manufacturing facility in Gujarat

Tue, Aug 10, 2021

The Covaxin vaccine received DCGI approval for Phase I and II Human Clinical Trials in July 2020.

BIG BOOST for Bharat Biotech's Covaxin! Vaccine receives certificate of Good Manufacturing Practices (GMP) from Hungary - Check details

BIG BOOST for Bharat Biotech's Covaxin! Vaccine receives certificate of Good Manufacturing Practices (GMP) from Hungary - Check details

Thu, Aug 05, 2021

A certificate of Good Manufacturing Practice (GMP) compliance has been received by Covaxin from the Hungarian authorities.

Covid 19: Decision on emergency use listing of Bharat Biotech's Covaxin likely in 4-6 weeks: WHO

Covid 19: Decision on emergency use listing of Bharat Biotech's Covaxin likely in 4-6 weeks: WHO

Sat, Jul 10, 2021

The World Health Organization (WHO) is likely to take a decision on including Bharat Biotech's COVID-19 vaccine Covaxin in the emergency use list (EUL) within four to six weeks, Soumya Swaminathan, the global health body's chief scientist has said.

CONFIDENCE BOOSTER! Covaxin 93.4% effective against severe symptomatic COVID-19 cases, 65.2% against new Delta variant, says Bharat Biotech

CONFIDENCE BOOSTER! Covaxin 93.4% effective against severe symptomatic COVID-19 cases, 65.2% against new Delta variant, says Bharat Biotech

Sat, Jul 03, 2021

Bharat Biotech has released safety and efficacy analysis data from Phase III clinical trials of COVAXIN®, a whole virion inactivated vaccine against SARS-CoV2.

Bharat Biotech's Covaxin efficacy results in Phase III trials: REVEALED!

Bharat Biotech's Covaxin efficacy results in Phase III trials: REVEALED!

Tue, Jun 22, 2021

Bharat Biotech's Covaxin has shown 77.8 percent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources, as per ANI.

DCGI expert panel meet today to review the Phase III data of Bharat Biotech's Covaxin - KEY EXPECTATIONS

DCGI expert panel meet today to review the Phase III data of Bharat Biotech's Covaxin - KEY EXPECTATIONS

Tue, Jun 22, 2021

The Subject Expert Committee (SEC) under the drug regulator will meet on Tuesday, June 22 to review the Phase III data of Bharat Biotech's Covaxin.

Hester has signed a drug substance production agreement with Bharat Biotech: Rajiv Gandhi, CEO & MD

Hester has signed a drug substance production agreement with Bharat Biotech: Rajiv Gandhi, CEO & MD

Fri, Jun 18, 2021

Rajiv Gandhi, CEO & Managing Director, Hester Biotech Limited, talks about March quarter performance, Covaxin and tie-up with Bharat Biotech, the international business among others during a chat with Swati Khandelwal, Zee Business.

Bharat Biotech is preparing nasal vaccine, injection vaccine will not be needed

Bharat Biotech is preparing nasal vaccine, injection vaccine will not be needed

Thu, May 13, 2021

Bharat Biotech is making nasal vaccine to fight the Coronavirus. This vaccine is given through the nose. Bharat Biotech has started its trial in Hyderabad.

Factsheet released on Corona Vaccine, know who should not get vaccinated

Factsheet released on Corona Vaccine, know who should not get vaccinated

Tue, Jan 19, 2021

Bharat Biotech and Serum Institute released a factsheet about Corona Vaccine, which tells about who should get the vaccine and who should not.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x